Skip to content.

Spotlight

Featured

Perspectives
Why we invested in Treefera
1 / 8
Read more
Perspectives
Why we invested in Oriole Networks
2 / 8
Read more
Perspectives
Why we invested in Gridcog
3 / 8
Read more
Perspectives
Why we invested in OpenDialog
4 / 8
Read more
Perspectives
Why we invested in kennek?
5 / 8
Read more
Perspectives
Why we invested in tem.?
6 / 8
Read more
Perspectives
Why we invested in Ramp?
7 / 8
Read more
Perspectives
Why we invested in 5Mins?
8 / 8
Read more

Perspectives

Bringing immuno-oncology cell therapies to the masses – are we (nearly) there yet?

Read the article >